These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 34877074)
101. Metastatic Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patient: A Systematic Review. Wackel M; Thomas S; Schmidt CM; Zheng C; Wysong A; Whitley MJ JID Innov; 2024 Sep; 4(5):100294. PubMed ID: 39258287 [TBL] [Abstract][Full Text] [Related]
102. Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival. Hirshoren N; Ruskin O; McDowell LJ; Magarey M; Kleid S; Dixon BJ Otolaryngol Head Neck Surg; 2018 Aug; 159(2):293-299. PubMed ID: 29533706 [TBL] [Abstract][Full Text] [Related]
103. Molecular prediction of metastasis in cutaneous squamous cell carcinoma. Mulvaney PM; Schmults CD Curr Opin Oncol; 2020 Mar; 32(2):129-136. PubMed ID: 31850970 [TBL] [Abstract][Full Text] [Related]
104. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. Wermker K; Kluwig J; Schipmann S; Klein M; Schulze HJ; Hallermann C Eur J Surg Oncol; 2015 Jan; 41(1):128-35. PubMed ID: 25182221 [TBL] [Abstract][Full Text] [Related]
105. PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. In GK; Vaidya P; Filkins A; Hermel DJ; King KG; Ragab O; Tseng WW; Swanson M; Kokot N; Lang JE; Menendez L; DeClerck B; Kim G; Hu JC; Terando A; Jadvar H; Ricker C; Miller KA; Peng DH; Wysong A J Cancer Res Clin Oncol; 2021 Jun; 147(6):1803-1811. PubMed ID: 33210210 [TBL] [Abstract][Full Text] [Related]
106. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma. Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377 [TBL] [Abstract][Full Text] [Related]
107. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study. Levine DE; Karia PS; Schmults CD JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278 [TBL] [Abstract][Full Text] [Related]
108. Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. Mourouzis C; Boynton A; Grant J; Umar T; Wilson A; Macpheson D; Pratt C J Craniomaxillofac Surg; 2009 Dec; 37(8):443-7. PubMed ID: 19713116 [TBL] [Abstract][Full Text] [Related]
109. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma. Nissinen L; Farshchian M; Riihilä P; Kähäri VM Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692 [TBL] [Abstract][Full Text] [Related]
110. Surgical outcomes for cutaneous squamous cell carcinoma of the auricle. Manole C; Skinner LJ; Donnelly MJ World J Otorhinolaryngol Head Neck Surg; 2023 Dec; 9(4):295-301. PubMed ID: 38059142 [TBL] [Abstract][Full Text] [Related]
111. Case Report: Dostarlimab for treatment of aggressive cutaneous squamous cell carcinoma. Gandarillas S; Tang H; Dasgeb B Front Med (Lausanne); 2024; 11():1322210. PubMed ID: 38529116 [TBL] [Abstract][Full Text] [Related]
112. Management of Locally Advanced Cutaneous Squamous Cell Carcinoma of the Scalp: A Case Report and Literature Review. Nuttall E; Hudnall RM; Richa T Cureus; 2023 Feb; 15(2):e34938. PubMed ID: 36938196 [TBL] [Abstract][Full Text] [Related]
113. Radiotherapy in the Adjuvant and Advanced Setting of CSCC. Muto P; Pastore F Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021168S. PubMed ID: 34877076 [TBL] [Abstract][Full Text] [Related]
114. What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patients. Eigentler TK; Dietz K; Leiter U; Häfner HM; Breuninger H Eur J Cancer; 2022 Sep; 172():182-190. PubMed ID: 35779310 [TBL] [Abstract][Full Text] [Related]
115. Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case-Control Study. Paganelli A; Zaffonato M; Donati B; Torricelli F; Manicardi V; Lai M; Spadafora M; Piana S; Ciarrocchi A; Longo C Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927938 [TBL] [Abstract][Full Text] [Related]
116. Surgery for Cutaneous Squamous Cell Carcinoma and its Limits in Advanced Disease. Moreno-Ramírez D; Silva-Clavería F; Fernández-Orland A; Eiris N; Ruiz de Casas A; Férrandiz L Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021167S. PubMed ID: 34877075 [TBL] [Abstract][Full Text] [Related]
117. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. Rabinowits G; Migden MR; Schlesinger TE; Ferris RL; Freeman M; Guild V; Koyfman S; Pavlick AC; Swanson N; Wolf GT; Dinehart SM JID Innov; 2021 Dec; 1(4):100045. PubMed ID: 34909742 [TBL] [Abstract][Full Text] [Related]
119. IMP3 Expression as a Potential Tumour Marker in High-Risk Localisations of Cutaneous Squamous Cell Carcinoma: IMP3 in Metastatic cSCC. Klein M; Wefers M; Hallermann C; Fischer HJ; Hölzle F; Wermker K Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627115 [TBL] [Abstract][Full Text] [Related]
120. Metastatic Axillary Cutaneous Squamous Cell Carcinoma in an African-American Female: A Rare Case. Sharif S; Markarian B; Marin D Cureus; 2024 Sep; 16(9):e68892. PubMed ID: 39376866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]